Medicure Inc. (OTCMKTS:MCUJF – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.65 and traded as low as $0.54. Medicure shares last traded at $0.54, with a volume of 9,000 shares traded.
Medicure Price Performance
The company’s 50 day moving average price is $0.55 and its 200-day moving average price is $0.65. The company has a market cap of $5.58 million, a price-to-earnings ratio of -3.82 and a beta of 0.98. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.64 and a current ratio of 2.03.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Articles
- Five stocks we like better than Medicure
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
